ANI Pharmaceuticals competitorsClear all
ANI Pharmaceuticals's top competitors include Dermavant Sciences and Merus.
 ANI Pharmaceuticals ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A. |  Dermavant Sciences Dermavant Sciences, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics in medical dermatology. |  Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. | |
Founding Date | Founding Date 1996 | Founding Date 2016 | Founding Date 2003 |
Type | Type Public | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations Baudette, US HQ Oakville, CA Baudette, US | Locations Long Beach, US HQ Basel, CH Durham, US Morrisville, US New York, US Phoenix, US | Locations Utrecht, NL HQ Cambridge, US |
Employees | Employees 33813% increase | Employees 13617% increase | Employees 1833% increase |
Alexa Website Rank | Alexa Website Rank 150691 | Alexa Website Rank 418800 | Alexa Website Rank 563795 |
Employee Rating | Employee Rating 3.5 | Employee Rating 4.9 | Employee Rating 4.2 |
Financial | |||
Revenue (est.) | Revenue (est.) $208.5m (FY, 2020) | Revenue (est.) N/A | Revenue (est.) $49.1m (FY, 2021) |
Cost of goods | Cost of goods $87.2m (FY, 2020) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $121.3m (FY, 2020) | Gross profit N/A | Gross profit $49.1m (FY, 2021) |
Net income | Net income ($22.5m) (FY, 2020) | Net income ($255.3m) (FY, 2019) | Net income ($66.8m) (FY, 2021) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 200m | Total funding raised $ 149.3m |
For sources of this data, please see the company profile
View company profiles
Dermavant Sciences
HQ
Long Beach, US
Dermavant Sciences, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics in medical dermatology.
View companyMerus
HQ
Utrecht, NL
Employees
183↑ 3% increase
Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
View company